Enter multiple symbols separated by commas

Salix-Cosmo deal worth watching

Wednesday, 9 Jul 2014 | 9:15 AM ET

Salix Pharmaceuticals has agreed to merge with Cosmo Pharmaceuticals. CNBC's David Faber and Jim Cramer discuss the growing trend of U.S companies shifting their tax domiciles abroad and why the Salix deal is worth keeping an eye on.